Drug Profile
Research programme: viral infection therapeutics - Viroblock
Alternative Names: VCCD Tech antiviral nasal spray - ViroblockLatest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Viroblock
- Class
- Mechanism of Action Viral envelope protein modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Influenza virus infections; Viral infections
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Influenza-virus-infections in Switzerland (Intranasal, Spray)
- 16 Jul 2016 No recent reports of development identified for preclinical development in Viral-infections in Switzerland
- 31 Mar 2009 Preclinical trials in Influenza virus infections in Switzerland (Intranasal)